The remainder of this paper is organized as follows. Section II describes the distributed architecture of platform and its software design pattern. Section III describes the DMH interfaces, and service creation and management. Next, the main applications of the robot and DMH are described in Section IV. Aspects of the platform support to diabetes management are presented and discussed in Section V along with some results obtained from a pilot clinical acceptability study. Finally, the work is concluded in Section VI.